Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational

Ninnutt Moonrin1, Napat Songtawee2, Siriluk Rattanabunyong3

  • 1Department of Biochemistry, Faculty of Science, Kasetsart University, 50 Ngam, Wong Wan Rd, Bangkok, Chatuchak, 10900, Thailand. moonrin_jear@hotmail.com.

BMC Bioinformatics
|April 18, 2015
PubMed
Abstract

Insights

Molecular dynamics simulations reveal how MIG-6 peptide binds to EGFR kinase, identifying key residues for interaction. This finding aids in designing new EGFR inhibitors for cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Computational Chemistry

Background:

  • Epidermal growth factor receptor (EGFR) signaling is crucial for cell functions.
  • EGFR overexpression drives human cancers, making it a key drug target.
  • MIG-6 protein suppresses EGFR by binding to its kinase domain.

Purpose of the Study:

  • Investigate protein-peptide interactions between EGFR kinase and a MIG-6 derived peptide.
  • Identify key residues and forces driving the binding interaction.
  • Provide insights for designing novel EGFR kinase inhibitors.

Main Methods:

  • Molecular dynamics (MD) simulations.
  • Binding free energy calculations using MM-PBSA.
  • Computational alanine scanning for residue analysis.

Main Results:

  • Identified six EGFR and eight MIG-6 residues critical for binding interface.
  • Van der Waals and non-polar solvation are favorable binding forces.
  • Calculations align with previous experimental mutagenesis studies.

Conclusions:

  • MD simulations elucidated MIG-6 peptide interactions with EGFR kinase.
  • Findings guide the design of novel anticancer therapeutics targeting EGFR.
  • The studied peptide interface may serve as an EGFR dimerization inhibitor.